ClinicalTrials.govpublic full text
Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
non small cell lung cancer, nsclc, egfr-mutated, egf816, inc280, nivolumab, egfr-t790m nsclc, egfr wild-type (wt), cmet positive nsclc, cmet negative nsclc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838071
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.